We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

192 hedge funds and large institutions have $221M invested in Immunogen Inc in 2019 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 63 increasing their positions, 53 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

187% more call options, than puts

Call options by funds: $2.47M | Put options by funds: $860K

19% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 53

9% less funds holding

Funds holding: 212 → 192 (-20)

31% less capital invested

Capital invested by funds: $320M → $221M (-$98.4M)

37% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 43

Holders
192
Holders Change
-20
Holders Change %
-9.43%
% of All Funds
4.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
63
Reduced
53
Closed
43
Calls
$2.47M
Puts
$860K
Net Calls
+$1.61M
Net Calls Change
-$1.11M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$5.9M
2
ClearBridge Investments
ClearBridge Investments
New York
+$3.77M
3
JP Morgan Chase
JP Morgan Chase
New York
+$3.23M
4
Millennium Management
Millennium Management
New York
+$2.22M
5
RG
Redmile Group
California
+$2.11M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$22.9M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$4.13M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.01M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$3.7M
5
Deutsche Bank
Deutsche Bank
Germany
-$3.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
FIM
51
Fernwood Investment Management
Massachusetts
$373K -$35.5K -15,000 -8%
TCM
52
Tekla Capital Management
Massachusetts
$365K – – –
William Blair & Company
53
William Blair & Company
Illinois
$362K +$217K +91,692 +122%
Fisher Asset Management
54
Fisher Asset Management
Washington
$355K +$62.4K +26,397 +19%
ARTA
55
A.R.T. Advisors
New York
$336K -$686K -290,216 -65%
Stifel Financial
56
Stifel Financial
Missouri
$320K +$141K +59,667 +46%
Marshall Wace
57
Marshall Wace
United Kingdom
$314K +$342K +144,493 New
Royal Bank of Canada
58
Royal Bank of Canada
Ontario, Canada
$308K +$39.1K +16,524 +13%
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$305K – – –
VEA
60
Virtus ETF Advisers
New York
$292K +$200K +84,659 +169%
UBS AM
61
UBS AM
Illinois
$287K – – –
Jacobs Levy Equity Management
62
Jacobs Levy Equity Management
New Jersey
$261K -$399K -168,840 -58%
Assenagon Asset Management
63
Assenagon Asset Management
Luxembourg
$257K +$280K +118,316 New
TFCP
64
Twin Focus Capital Partners
Massachusetts
$245K – – –
JC
65
JBF Capital
Colorado
$217K +$236K +100,000 New
Manulife (Manufacturers Life Insurance)
66
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$211K -$194 -82 -0.1%
HF
67
HRT Financial
New York
$207K +$226K +95,505 New
AIG
68
American International Group
New York
$200K +$1.6K +676 +0.7%
CHAM
69
Clear Harbor Asset Management
Connecticut
$200K +$218K +92,100 New
UBS Group
70
UBS Group
Switzerland
$194K -$87.5K -36,990 -29%
BTS
71
BB&T Securities
Virginia
$192K -$4.42K -1,867 -2%
CS
72
Credit Suisse
Switzerland
$186K -$99.5K -42,093 -33%
DekaBank Deutsche Girozentrale
73
DekaBank Deutsche Girozentrale
Germany
$185K +$83K +35,100 +64%
VF
74
Virtu Financial
New York
$185K +$138K +58,389 +216%
ERSOT
75
Employees Retirement System of Texas
Texas
$174K – – –
1 2
3
4 5

IMGN Hedge Fund Activity: Q2 2019 in Review

192 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2019, worth a combined $221M — down 31% from $320M a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of IMGN and 27 opened new positions — a net loss of 16 holders — while 53 trimmed existing stakes and 63 added.

The largest buyer was Morgan Stanley, adding an estimated $5.9M. The largest seller was State Street, cutting an estimated $22.9M.

  • 192 institutional investors held Immunogen Inc (IMGN) as of Q2 2019, down from 212 in Q1 2019.
  • Funds reported $221M of Immunogen Inc stock for Q2 2019, down 31% quarter-over-quarter.
  • 27 funds opened new Immunogen Inc positions in Q2 2019 and 43 closed out, a net change of -16 holders.
  • The largest Immunogen Inc buyer in Q2 2019 was Morgan Stanley, an estimated $5.9M added.
  • The largest Immunogen Inc seller in Q2 2019 was State Street, an estimated $22.9M sold.

Based on aggregated 13F filings for Q2 2019.